Clinical Trials Directory

Trials / Completed

CompletedNCT05828004

The SHINE-MDT Randomized Controlled Trial

Effect of Multidisciplinary Team Support on Head and Neck Cancer Patients Receiving Radiotherapy: The SHINE-MDT Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
233 (actual)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Radiotherapy is one of the main treatments for head and neck Carcinoma. The incidence of radiotherapy-related adverse events is greater than 90%, and severe adverse events may lead to the interruption of radiotherapy. The management of nutritional, psychological, and rehabilitative issues in patients undergoing radiotherapy for head and neck cancer presents unique clinical challenges. We aimed to evaluate the efficacy of the SHINE-MDT (Supportive Holistic Interventions by Nurses and Experts via Multidisciplinary Team) in reducing radiotherapy interruptions and improving patients' quality of life (QoL) compared with usual care.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWhole-Course Multidisciplinary Care InterventionOn the basis of standard treatment, all patients were evaluated by senior practice nurses in the Department of Oncology in person at the time of enrollment (before radiotherapy) and once every week during radiotherapy, and once in person/over the phone at 1, 2, 3, and 6 months after radiotherapy.

Timeline

Start date
2023-04-27
Primary completion
2023-12-01
Completion
2024-06-01
First posted
2023-04-25
Last updated
2025-08-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05828004. Inclusion in this directory is not an endorsement.